Genoray Co., Ltd. (KOSDAQ:122310)
3,340.00
-130.00 (-3.75%)
At close: Jun 19, 2026
Genoray Revenue
Genoray had revenue of 25.39B KRW in the quarter ending March 31, 2026, with 0.90% growth. This brings the company's revenue in the last twelve months to 108.27B, up 1.10% year-over-year. In the year 2025, Genoray had annual revenue of 108.04B with 0.99% growth.
Revenue (ttm)
108.27B
Revenue Growth
+1.10%
P/S Ratio
0.37
Revenue / Employee
300.75M
Employees
360
Market Cap
40.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 108.04B | 1.06B | 0.99% |
| Dec 31, 2024 | 106.98B | 9.08B | 9.28% |
| Dec 31, 2023 | 97.90B | 15.29B | 18.51% |
| Dec 31, 2022 | 82.60B | 8.31B | 11.19% |
| Dec 31, 2021 | 74.29B | 12.60B | 20.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 106.74B |
| CU Medical Systems | 54.66B |
| JPI Healthcare | 47.97B |
| SELVAS Healthcare | 30.19B |
| Dynamic solution | 15.46B |
| MEKICS CO., | 12.26B |
| Noul Co.,Ltd. | 4.05B |
| QuantaMatrix | 3.40B |